Strategies to Improve Long Term Islet Graft Survival.
Phase of Trial: Phase II
Latest Information Update: 28 Apr 2016
At a glance
- Drugs Lisofylline (Primary) ; Antithymocyte globulin; Basiliximab; Sirolimus; Tacrolimus
- Indications Islet cell transplant rejection; Type 1 diabetes mellitus
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 18 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 12 Jan 2012 Actual patient number is 5 according to ClinicalTrials.gov.